| Autor: |
Kohlhas P; Department of Ophthalmology, Saarland University Medical Center, Kirrberger Straße 100, 66424 Homburg, Germany., Abdin AD; Department of Ophthalmology, Saarland University Medical Center, Kirrberger Straße 100, 66424 Homburg, Germany., Aljundi W; Department of Ophthalmology, Saarland University Medical Center, Kirrberger Straße 100, 66424 Homburg, Germany., Mattern AI; Internationale Innovative Ophthalmochirurgie GbR (I.I.O.), Theo-Champion-Str. 1, 40549 Düsseldorf, Germany., Devenijn M; Internationale Innovative Ophthalmochirurgie GbR (I.I.O.), Theo-Champion-Str. 1, 40549 Düsseldorf, Germany., Borchert K; Xcenda GmbH, Part of Cencora, Lange Laube 31, 30159 Hannover, Germany., Fricke A; Internationale Innovative Ophthalmochirurgie GbR (I.I.O.), Theo-Champion-Str. 1, 40549 Düsseldorf, Germany., Viering T; Xcenda GmbH, Part of Cencora, Lange Laube 31, 30159 Hannover, Germany., Wasem J; Department for Health Care Management, University Duisburg-Essen, Thea-Leymann-Str. 9, 45127 Essen, Germany., Seitz B; Department of Ophthalmology, Saarland University Medical Center, Kirrberger Straße 100, 66424 Homburg, Germany., Kaymak H; Internationale Innovative Ophthalmochirurgie GbR (I.I.O.), Theo-Champion-Str. 1, 40549 Düsseldorf, Germany.; Gottfried O.H. Naumann-Institute of Epidemiology and Prevention of Myopia, Saarland University, 66424 Homburg, Germany. |
| Abstrakt: |
Background/Objectives: Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) leading to the progressive and irreversible loss of visual function. Characteristics of GA include atrophic lesions resulting from the loss of photoreceptors, retinal pigment epithelium, and choriocapillaris. During GA progression, atrophic lesions typically advance from the macular periphery to the center, affecting foveal light sensitivity and visual acuity. This study analyzed changes in light sensitivity and visual acuity during the natural course of GA progression using the topographic analysis of structural and functional changes based on Early Treatment Diabetic Retinopathy Study (ETDRS) charts, multimodal imaging, and microperimetry assessment. Methods: Medical chart data of GA patients between 2014 and 2022 from the Internationale Innovative Ophthalmochirurgie GbR (I.I.O.) research center (Düsseldorf, Germany) were retrospectively analyzed. All patient eyes fulfilling the phase 3 OAKS study inclusion criteria were included and followed up for 60 months. The imputation of missing measurements and dropouts was performed by linear mixed models. Results: A total of 20 GA eyes from 13 GA patients were included in the study. At the index, 53.8% of patients had bilateral GA, with 70.0% of the eyes showing multifocal GA and 30.0% subfoveal encroachment (SFE). A total of 35.0% of the eyes had 2-5, and 15.0% over 20, areas of atrophy. Over time, the GA lesion size increased from 6.4 mm 2 to 11.8 mm 2 (1.08 mm 2 /year). After an average observation time of 2.9 years, 78.6% of the initially unaffected study eyes developed SFE. The percentage of study eyes without visual impairment decreased from 55.0% to 30.0%, with mean normal-luminance best-corrected visual acuity (NL-BCVA) reducing from 63.7 to 55.7 ETDRS letters. The share of absolute scotoma points in microperimetry assessment increased from 15.7% to 43.5% while overall average macular sensitivity declined from 15.7 dB to 7.4 dB. Conclusions: The substantial deterioration of macular outcomes and visual function was comprehensively detected. The results were a documentation of structural and functional aspects of the natural progression of GA for a 60-month follow-up, providing a typical outline for AMD patients with GA. |
